Outgoing FDA officials attack Biden’s vaccine booster plan

Published



Two outgoing members of the Food and Drug Administration’s Office of Vaccines Research and Review were among the authors of an academic paper criticizing President Joe Biden’s plan for increased COVID-19 booster vaccines.

Director Marion Gruber and Deputy Director Phil Krause announced their resignations from the FDA on Aug. 31 and are set to leave this fall. Current administration sources told Politico that the pair resigned due to disagreements between the Biden administration and the agency over the efficacy of booster shots for the coronavirus vaccines.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.